ZBiotics
PrivateLast Round
Series A
Aug 27, 2024
Est. Valuation
$1.71M
Total Funding Raised
$17.7M
Company Overview
ZBiotics operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in August 2024.
ZBiotics is a biotechnology company that develops genetically engineered probiotics designed to improve human health by addressing everyday biological challenges, such as breaking down alcohol byproducts and converting sugar into fiber.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, E-commerce
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ZBiotics Comparables
Compare ZBiotics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| More Labs | 84% | |
| de Faire Medical AB | 80% | |
| No Days Wasted | 80% |
For institutional investors. Book with your work email.
ZBiotics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 27, 2024 | ||||
| Seed | Mar 12, 2020 | ||||
| Accelerator | Aug 7, 2018 | ||||
| Seed | Mar 21, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ZBiotics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Utopian Ventures | Seed |
| Oyster Ventures | Seed |
| Access Capital | Series A |
| Seamless Capital | Series A |
| BABEL Ventures | Seed |
| Babel Ventures | Seed |
| Seamless Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2024
$12M round completed.
- Jan 1, 2024
Sugar-to-Fiber, a probiotic drink mix, is launching in 2024.
For institutional investors. Book with your work email.
ZBiotics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ZBiotics's valuation, stock price, and market status.
Is ZBiotics a public or private company?
ZBiotics is a private company.
What is the current stock price of ZBiotics?
ZBiotics is a private company, so its shares have no public market price. Caplight tracks ZBiotics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ZBiotics worth (valuation)?
ZBiotics's valuation is estimated at $1.7M based on funding round data.
Can I buy ZBiotics stock?
ZBiotics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ZBiotics's last funding round?
ZBiotics's most recent funding round was Series A on August 27, 2024.
Who are the main investors in ZBiotics?
Key investors in ZBiotics include Utopian Ventures, Oyster Ventures, BABEL Ventures, Babel Ventures, Y Combinator.
Will ZBiotics IPO soon?
No public IPO plans have been announced for ZBiotics.
How can I track ZBiotics secondary market activity?
Caplight tracks bids, offers, and trades in ZBiotics's shares on secondary markets.